Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GeneDx Holdings (WGS) Interest & Investment Income (2020 - 2026)

GeneDx Holdings has reported Interest & Investment Income over the past 7 years, most recently at -$717000.0 for Q1 2026.

  • Quarterly Interest & Investment Income fell 12.03% to -$717000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.6 million through Mar 2026, up 14.93% year-over-year, with the annual reading at -$2.5 million for FY2025, 16.26% up from the prior year.
  • Interest & Investment Income was -$717000.0 for Q1 2026 at GeneDx Holdings, down from -$520000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.1 million in Q4 2022 and troughed at -$978000.0 in Q4 2023.
  • The 5-year median for Interest & Investment Income is -$562000.0 (2025), against an average of -$109764.7.
  • Year-over-year, Interest & Investment Income skyrocketed 5063.64% in 2022 and then tumbled 186.09% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $1.1 million in 2022, then tumbled by 186.09% to -$978000.0 in 2023, then grew by 28.63% to -$698000.0 in 2024, then increased by 25.5% to -$520000.0 in 2025, then crashed by 37.88% to -$717000.0 in 2026.
  • Per Business Quant, the three most recent readings for WGS's Interest & Investment Income are -$717000.0 (Q1 2026), -$520000.0 (Q4 2025), and -$562000.0 (Q3 2025).